TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27004388

Group type: EXPERIMENTAL
Intervention: McGRATH MAC video laryngoscope
Number of subjects: 80

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 80
Study: 23825004

Group type: EXPERIMENTAL
Intervention: Variable resistance training
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Constant resistance training
Number of subjects: 37

Group type: COMPARATOR
Intervention: Non-training control group
Number of subjects: 37
Study: 22264303

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (10 grams with normal saline)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo (normal saline only)
Number of subjects: 141
Study: 19172129

Group type: EXPERIMENTAL
Intervention: Galacto-oligosaccharides (GOS) 5 g/L
Number of subjects: 159

Group type: COMPARATOR
Intervention: Standard follow-on formula (control)
Number of subjects: 159
Study: 17224283

Group type: EXPERIMENTAL
Intervention: SCD EXPRESS Compression System
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Four-layer bandage
Number of subjects: 18

Group type: COMPARATOR
Intervention: No bandage
Number of subjects: 18
Study: 15975373

Group type: EXPERIMENTAL
Intervention: CorX system (group A)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standard CPB (group B)
Number of subjects: 204
Study: 11944885

Group type: EXPERIMENTAL
Intervention: Sepiapterin and 6-biopterin photo-oxidation by UVA/UVB irradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: UVA/UVB irradiation
Number of subjects: 0
Study: 11487138

Group type: EXPERIMENTAL
Intervention: Apical trephination
Number of subjects: 50

Group type: COMPARATOR
Intervention: Mock trephination
Number of subjects: 50
Study: 9771245

Group type: EXPERIMENTAL
Intervention: Increased dose of inhaled steroids
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 7829006

Group type: EXPERIMENTAL
Intervention: Zinc acetate (15 mg/kg per day) for a month
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (without zinc)
Number of subjects: 32
Study: 3407604

Group type: EXPERIMENTAL
Intervention: Low glycemic index (GI) foods
Number of subjects: 8

Group type: COMPARATOR
Intervention: High glycemic index (GI) foods
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High GI and Low GI foods
Number of subjects: 8
Study: 7525446

Group type: EXPERIMENTAL
Intervention: GCSF primed peripheral blood progenitor cell collections
Number of subjects: 62

Group type: COMPARATOR
Intervention: Post chemotherapy GCSF
Number of subjects: 62
Study: 748987

Group type: EXPERIMENTAL
Intervention: Vaginal 15-methyl-PGF2alpha methyl ester (3.0 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intra-amniotic PGF2alpha (50 mg)
Number of subjects: 100
Study: 31003804

Group type: EXPERIMENTAL
Intervention: Smoke-Free Moms intervention (financial incentives)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Usual smoking counseling (Control)
Number of subjects: 175
Study: 29861487

Group type: EXPERIMENTAL
Intervention: Vitamin D fortified foods (12 weeks trial)
Number of subjects: 534
Study: 26825916

Group type: EXPERIMENTAL
Intervention: Facilitative Kinesio Taping (KT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Inhibitory Kinesio Taping (KT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Hypafix taping
Number of subjects: 28
Study: 24801369

Group type: EXPERIMENTAL
Intervention: Whey protein
Number of subjects: 70

Group type: COMPARATOR
Intervention: Casein protein
Number of subjects: 70

Group type: COMPARATOR
Intervention: Glucose control
Number of subjects: 70
Study: 22507444

Group type: EXPERIMENTAL
Intervention: Repetitive focal muscle vibration (rMV)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo vibratory treatment (Control Group)
Number of subjects: 49
Study: 21054290

Group type: EXPERIMENTAL
Intervention: Behavior change intervention (BCI)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: BCI plus pedometer (pedometer plus)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Secondary outcomes (not specified)
Number of subjects: 204
Study: 17652313

Group type: EXPERIMENTAL
Intervention: Doppler echocardiography
Number of subjects: 163

Group type: COMPARATOR
Intervention: Invasive measurement (right heart catheterisation)
Number of subjects: 163
Study: 15782425

Group type: EXPERIMENTAL
Intervention: 7.5% CO2 inhalation for 20 min
Number of subjects: 20

Group type: COMPARATOR
Intervention: Air inhalation for 20 min
Number of subjects: 20
Study: 12404882

Group type: EXPERIMENTAL
Intervention: Amiloride (20 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 10101361

Group type: EXPERIMENTAL
Intervention: CT fluoroscopy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional CT guidance
Number of subjects: 20
Study: 7582380

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (751 mg/l naringin)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Water
Number of subjects: 12
Study: 2348453

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Video game
Number of subjects: 108
Study: 6997537

Group type: EXPERIMENTAL
Intervention: KW-1062 at 240 mg/day
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: KW-1062 at 360 mg/day
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: KW-1062 for acute and uncomplicated pyelonephritis
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: KW-1062 (both doses)
Number of subjects: 155
Study: 30898609

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18924

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924
Study: 29184389

Group type: EXPERIMENTAL
Intervention: ETV from Dong‐A ST (Baracle®)
Number of subjects: 118

Group type: COMPARATOR
Intervention: ETV from BMS (Baraclude®)
Number of subjects: 118
Study: 25488053

Group type: EXPERIMENTAL
Intervention: Vitamin C
Number of subjects: 4
Study: 24592747

Group type: EXPERIMENTAL
Intervention: Tocotrienol-rich fraction (TRF) of palm oil, 100 mg daily from early second trimester until delivery
Number of subjects: 299

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Tocotrienol-rich fraction (TRF) of palm oil
Number of subjects: 299
Study: 22847319

Group type: EXPERIMENTAL
Intervention: Tretinoin cream products (three concentrations)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tretinoin gel products (two concentrations)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tretinoin (same concentration) in different vehicles (gel vs. cream)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tretinoin and adapalene (same concentration)
Number of subjects: 0
Study: 19279367

Group type: EXPERIMENTAL
Intervention: Pyritinol
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 17122430

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis with alteplase
Number of subjects: 6

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 6
Study: 14962945

Group type: EXPERIMENTAL
Intervention: Subantimicrobial doses of doxycycline (SDD) 20 mg twice daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 12166350

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg midazolam intramuscularly
Number of subjects: 22

Group type: COMPARATOR
Intervention: No pre‐medication
Number of subjects: 22
Study: 9856369

Group type: EXPERIMENTAL
Intervention: 1.5 mg sustained-release indapamide
Number of subjects: 690
Study: 7596722

Group type: EXPERIMENTAL
Intervention: Amoxicillin for days 1 through 10, then amoxicillin for days 11 through 20
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Amoxicillin for days 1 through 10, then amoxicillin-clavulanate for days 11 through 20
Number of subjects: 267

Group type: COMPARATOR
Intervention: Amoxicillin for days 1 through 10, then placebo for either amoxicillin or amoxicillin-clavulanate for days 11 through 20
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study: 2229526

Group type: EXPERIMENTAL
Intervention: terbinafine 1% cream
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo (cream vehicle)
Number of subjects: 30
Study: 873028

Group type: EXPERIMENTAL
Intervention: 50 mg amitriptyline once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: 30 mg nortriptyline with 1-5 mg fluphenazine once daily
Number of subjects: 0
Study: 30153811

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM) 1000‐1500mg iron
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ferrous sulfate (FS) 200mg iron/day
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ferrous sulfate (FS)
Number of subjects: 90
Study: 27501836

Group type: EXPERIMENTAL
Intervention: Medial Opening Wedge HTO (OWHTO)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lateral Closing Wedge HTO (CWHTO)
Number of subjects: 60
Study: 24641777

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Exercise + Psychosexual
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 240
Study: 22544917

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 8
Study: 20168213

Group type: COMPARATOR
Intervention: Nicotine inhalers (NI)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo inhalers (PI)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nicotine-containing tobacco (NT)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Denicotinized tobacco (DT)
Number of subjects: 22
Study: 17396617

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oral trapidil (200 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oral isosorbide dinitrate (20 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intravenous trapidil (100 mg)
Number of subjects: 18
Study: 15590711

Group type: EXPERIMENTAL
Intervention: Experimental group (additional objective of increasing MVPA)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no additional objective)
Number of subjects: 21
Study: 12085418

Group type: EXPERIMENTAL
Intervention: Verapamil SR/Trandolapril 180/2 mg/day (VT)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Losartan/Hydrochlorothiazide 20/12.5 mg/day (LH)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 77
Study: 9593032

Group type: EXPERIMENTAL
Intervention: Trivalent cold-adapted influenza vaccine (CAIV-T) at high dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trivalent cold-adapted influenza vaccine (CAIV-T) at low dose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trivalent cold-adapted influenza vaccine (CAIV-T) administered by drops
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trivalent cold-adapted influenza vaccine (CAIV-T) administered by spray
Number of subjects: 0
Study: 7551834

Group type: EXPERIMENTAL
Intervention: Interferon-alpha
Number of subjects: 558

Group type: COMPARATOR
Intervention: Control (ECOG chemotherapy protocols)
Number of subjects: 558

Group type: COMPARATOR
Intervention: Control (medroxyprogesterone acetate)
Number of subjects: 558
Study: 2230272

Group type: EXPERIMENTAL
Intervention: Selective decontamination (polymyxin, gentamicin, and nystatin as oral paste and solution)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Selective decontamination
Number of subjects: 107

Group type: COMPARATOR
Intervention: Sucralfate
Number of subjects: 107
Study: 710319

Group type: EXPERIMENTAL
Intervention: Dopamine (4 microgram/kg . min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dobutamine (7.5 microgram/kg . min)
Number of subjects: 10
Study: 31959235

Group type: EXPERIMENTAL
Intervention: Blended CBT (MS Fit)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Face-to-face CBT
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: MS Stay Fit (two booster sessions at 2 and 4 months after end of treatment)
Number of subjects: 166

Group type: COMPARATOR
Intervention: No booster sessions
Number of subjects: 166
Study: 30076458

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 28
Study: 28556449

Group type: EXPERIMENTAL
Intervention: 1.8 mg beloranib
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 2.4 mg beloranib
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 25906563

Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding at cervical Jiaji (EX-B 2) points combined with electroacupuncture (EA) at acupoints near ears
Number of subjects: 63

Group type: COMPARATOR
Intervention: Electroacupuncture (EA) at regular acupoints near ears alone
Number of subjects: 63
Study: 23108415

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.5 µg/kg/h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 0
Study: 21881533

Group type: EXPERIMENTAL
Intervention: Sun-dried raisins (SDRs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sports Jelly Beans (SJBs)
Number of subjects: 10
Study: 19020851

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Stent-protected angioplasty (CAS)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 27
Study: 17195608

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interventional management (medical treatment, early coronarography, revascularization)
Number of subjects: 0
Study: 14624703

Group type: EXPERIMENTAL
Intervention: Baclofen (60 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10856317

Group type: EXPERIMENTAL
Intervention: Women with LAM
Number of subjects: 15
Study: 9104901

Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg/day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 7523739

Group type: EXPERIMENTAL
Intervention: Methotrexate (50 mg/m²) + Misoprostol (800 mcg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Misoprostol (800 mcg) alone
Number of subjects: 63
Study: 3366415

Group type: EXPERIMENTAL
Intervention: 1 mg dose of trans-anethole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50 mg dose of trans-anethole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 250 mg dose of trans-anethole
Number of subjects: 0
Study: 30104494

Group type: EXPERIMENTAL
Intervention: Greater vegetable diversity (per increase in one different vegetable/day)
Number of subjects: 1429

Group type: EXPERIMENTAL
Intervention: Higher vegetable diversity in women with low vegetable intake (<2.2 servings/day)
Number of subjects: 1429
Study: 25286691

Group type: EXPERIMENTAL
Intervention: Injectable cefetamet sodium (500 mg, 1,000 mg, 2,000 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Injectable cefetamet sodium (500 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Injectable cefetamet sodium (1,000 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Injectable cefetamet sodium (2,000 mg)
Number of subjects: 60
Study: 22247421

Group type: EXPERIMENTAL
Intervention: Personalized noninteractive website
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personalized interactive website
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control website (nonindividualized risk information)
Number of subjects: 0
Study: 19298635

Group type: EXPERIMENTAL
Intervention: Budesonide 200 μg once daily in the morning
Number of subjects: 52

Group type: COMPARATOR
Intervention: Montelukast 5 mg once daily
Number of subjects: 52
Study: 18199095

Group type: EXPERIMENTAL
Intervention: Intravenous L-carnitine supplementation
Number of subjects: 0
Study: 16050414

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin II blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concomitant use of statins and angiotensin II blockers
Number of subjects: 0
Study: 14500112

Group type: EXPERIMENTAL
Intervention: Light therapy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study: 10652037

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 8540513

Group type: EXPERIMENTAL
Intervention: Nasal oxygen (2 L/min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Room air (no oxygen)
Number of subjects: 30
Study: 2178334

Group type: COMPARATOR
Intervention: dideoxycytidine (ddC) at 0.1 and 1 microM
Number of subjects: 0

Group type: COMPARATOR
Intervention: dideoxyinosine (ddI) at 0.2 to 50 microM
Number of subjects: 0

Group type: COMPARATOR
Intervention: dideoxyinosine (ddI) at 2 microM
Number of subjects: 0

Group type: COMPARATOR
Intervention: dideoxyinosine (ddI)
Number of subjects: 0
Study: 7031982

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin fraction
Number of subjects: 6

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 6

Group type: COMPARATOR
Intervention: High molecular weight heparin fraction
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: All heparin preparations
Number of subjects: 6
Study: 31551227

Group type: EXPERIMENTAL
Intervention: External application of Liuhe Dan
Number of subjects: 160

Group type: COMPARATOR
Intervention: Routine nursing methods (Control)
Number of subjects: 160
Study: 28237635

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 92
Study: 25765966

Group type: EXPERIMENTAL
Intervention: Concomitant administration of ProQuad(®) and hexavalent vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ProQuad(®) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hexavalent vaccine alone
Number of subjects: 0
Study: 22956676

Group type: EXPERIMENTAL
Intervention: Cognitive-based compassion training (CBCT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Health discussion control group
Number of subjects: 21
Study: 22069974

Group type: EXPERIMENTAL
Intervention: Arthroscopy assisted percutaneous internal fixation
Number of subjects: 58

Group type: COMPARATOR
Intervention: Open reduction and internal fixation
Number of subjects: 58
Study: 19680681

Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise (four 2-min isometric contractions at 30% MVC)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise
Number of subjects: 18

Group type: COMPARATOR
Intervention: Time-matched control condition
Number of subjects: 18
Study: 17257728

Group type: EXPERIMENTAL
Intervention: Bilateral presentations of distractors (either a word or a pseudoword)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bilateral presentations with perceptual distractors (sequences of the letter 'x')
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comparison of performance patterns on trials with perceptual and lexical distractors
Number of subjects: 0
Study: 15531055

Group type: EXPERIMENTAL
Intervention: Controlled loading protocol (three, 3-min posterior to anterior normalized loads directed to the posterior calf)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control limb (one knee served as control)
Number of subjects: 0
Study: 11320361

Group type: EXPERIMENTAL
Intervention: Accelerated TPA with reduced heparin dose mid-trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Accelerated TPA with lowest heparin dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-bolus TNK-TPA and lanoteplase with reduced heparin dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower-dose, weight-adjusted heparin regimen (60 U/kg bolus; maximum, 4000 U; 12 U/kg per hour infusion; maximum, 1000 U/h)
Number of subjects: 0
Study: 9447478

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/day for 3 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Thiothixene (20 mg single oral dose)
Number of subjects: 10
Study: 8070160

Group type: EXPERIMENTAL
Intervention: Elemental diet for 3 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control soup (milk, meat, fish, shellfish, orange, pineapples, tomatoes, peas, flour of wheat and corn) for 3 weeks
Number of subjects: 17
Study: 2970203

Group type: EXPERIMENTAL
Intervention: Paroxetine (30 mg daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Mianserin (60 mg daily)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 70
Study: 31726241

Group type: EXPERIMENTAL
Intervention: Experimental group (disappointed before cognitive task)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control group (not disappointed before cognitive task)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Experimental group (children expressing appreciative positive emotions)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Experimental group (children expressing negative emotions or no reaction)
Number of subjects: 148
Study: 29788487

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 333

Group type: COMPARATOR
Intervention: Weight loss
Number of subjects: 333
Study: 28902705

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D (120,000 IU/monthly)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Moderate dose vitamin D (60,000 IU/monthly)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Standard/control dose vitamin D (18,000 IU/monthly)
Number of subjects: 102
Study: 26303780

Group type: EXPERIMENTAL
Intervention: MFGM (1 g)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 24030722

Group type: EXPERIMENTAL
Intervention: Campaign materials (mainly posters, brochures, and advertisements on local media, plus a newsletter on local antibiotic resistance targeted at doctors and pharmacists)
Number of subjects: 1150000

Group type: EXPERIMENTAL
Intervention: Campaign materials
Number of subjects: 1150000